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It has become a new challenge for the new generation of 
medical science to prepare the most effective drug for the 
proper treatment of different types of cancers1-7. To make 
the treatment, more effective medical scientists have tried to 
increase the use of nanoparticles so that drug delivery into 
the exact location becomes possible. Apart from this, the 
introduction of exosomes is also taking place for recognizing 
and treatment of various cancers. Similarly, DNA 
methylation and histone modification have importance in the 
treatment of tumors. Therefore, the introduction of 
nanotechnology for drug delivery at the exact location of the 
human body has seen tremendous success in the passing 
years. Some specific methods of delivering different 
chemotherapeutic drugs at the correct place have been 
discovered to get the most positive impact8-18. 
Cancer mainly spread through the human body because of 
excessive cell growth and some nano-sized 
chemotherapeutic drugs has been invented specially for 
repressing those excessive cell growth. Sometimes, those 
drugs help to suppress the propagation of cancer-causing 
genes in the human body. On the other hand, Doxorubicin 
(DOC) is widely used in these days to control the excessive 
spread of malignant tumor in the human body. Hence, the 
introduction of nanoparticles is the only way out in this 
regard to control numerous cancer-causing cells and genes 
in human19-29. That not only delivers multiple drugs into the 
exact location but also sometimes helps to diagnose the 
disease early.  
In this process, a methyl group gets added with DNA that 
retains the DNA structure intact but changes its functionality. 
Therefore, it helps to destroy the cancerous cells.  
Exosomes are mostly used in this kind of early detection of 
cancerous cells in the human body. Being extracellular 
organelles, it becomes easier for the exosomes to get both 
proteomic and genetic information from extended distant 
intracellular areas. This helps to identify the affected area 
more easily and early30-34. Apart from that, AntimiR-21 is a 
kind of oligonucleotide that gets combined with 
nanoparticles to improve its impact on the diseased area. It 
is a combination of tertiary amine cationic lipid with a 
quaternary amine, which is distinctively designed with the 
characteristics of proper pH value.  
In these days, the use of exosomes has been increased as an 
early detector of cancerous genes and cells growth in the 
human body. Similarly, the use of microRNA has been started 
to control the excessive gene expression as the microRNAs 
are capable of doing this by RNA interference into the 
affected body part. Incorporation of oligonucleotides into the 
nanoparticle of lipids helps the address the problems of 
nucleus sensitivity of anti-MiRs. Unless this incorporation, 
the anti-MiRs will never function properly. Nucleus 
sensitivity will cause its faster removal from the blood 
circulating vessels. Along with it, due to high charge density 
and higher molecular weight anti-MiRs will fail to penetrate 
the cellular membrane. Apart from this, to control the impact 
of Bcl-2 and Akt-1 carcinogens in the human body the use of 
lipid nanoparticles with T7 peptide conjugation are 
increasing. It is mainly helping to cure cervical and lung 
carcinomas35-40. Not only anti-MiRs or nanoparticles are used 
in cancer treatment, but also the use of DNA methylation has 
been increased to understand the cases of somatic cell 
reprogramming and tumorigenesis41-51. 
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Figure 1: Bimodal DNA Methylation30.  
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